Sorry, you need to enable JavaScript to visit this website.

Pfizer supports the global healthcare community’s independent initiatives (e.g., research, quality improvement or education) to improve patient outcomes in areas of unmet medical need that are aligned with Pfizer’s medical and/or scientific strategies.

Pfizer’s competitive grant program involves a publicly posted Request for Proposal (RFP) that provides detail regarding a specific area of interest and sets timelines for review and approval. Organizations are invited to submit an application addressing the specific gaps in research, practice or care as outlined in the specific RFP. The grant requester (and ultimately the grantee) is responsible for the design, implementation, sponsorship, and conduct of the independent initiative supported by the grant, including compliance with any regulatory requirements.

Sign-up to receive all GMG announcements, including Request for Proposal (RFP) postings.

Sign Up for Alerts Details
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Improving the Care Process for Patients with Advanced Prostate Cancer
    Release Date:
    Partner: The American Urological Association Education and Research, Inc.; Astellas
    Review Process: Expert Review Panel
    Quality Improvement Oncology USA
    Developing Educational Initiatives for ALK+ Metastatic Non-small Cell Lung Cancer Tyrosine Kinase Inhibitors Therapy
    Release Date:
    Review Process: Pfizer Internal
    Translation: French (link)
    Education Oncology Canada
    Accelerating biomarker testing for optimized metastatic colorectal cancer treatment planning across Canada
    Release Date:
    Partner: Colorectal Cancer Canada (CCC)
    Review Process: Expert Review Panel
    Translation: French (link)
    Quality Improvement, Research Oncology Canada
    Transthyretin Cardiac Amyloidosis Fellowship - United States
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Rare Disease USA
    Exploring the Use of Artificial Intelligence (AI) Applications in ALK+ NSCLC
    Release Date:
    Review Process: Expert Review Panel
    Quality Improvement, Research Oncology Italy
    Advances in Migraine Management
    Release Date:
    Review Process: Pfizer Internal
    Education Internal Medicine USA
    Sickle Cell Disease (SCD) Fellowship
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Rare Disease USA
    2025 Headache Medicine Fellowship - US
    Release Date:
    Review Process: Expert Review Panel
    Fellowship Internal Medicine USA
    Sickle Cell Disease Visiting Professorship Program
    Release Date:
    Review Process: Pfizer Internal
    Education Rare Disease USA
    Optimizing Care for Patients with HR+/HER2- or HER2+ (regardless of hormonal status) metastatic Breast Cancer (mBC)
    Release Date:
    Review Process: Pfizer Internal
    Education Oncology Spain
    Research on Diagnostic and Treatment of Invasive Mold Disease
    Release Date:
    Review Process: Pfizer Internal
    Research Hospital China
  • Title
    Grant Type
    Focus Area
    Country
    Application Due Date
    Quality Improvement initiatives optimizing AF and VTE management in Canada
    Release Date:
    Review Process:
    Improving the Management of Patients with Uncontrolled Acromegaly (International Developed Markets)
    Release Date:
    Review Process:
    Pfizer and the National Kidney Foundation: Improving Immunization Rates of Patients with Chronic Kidney Disease Including Dialys
    Release Date:
    Review Process: Pfizer Internal
    Education Hospital Albania
    Integrated Approach to Breast Health Equity
    Release Date:
    Review Process:
    Patient Registries In Metastatic Breast Cancer
    Release Date:
    Review Process:
    Improving Patient Care in Tobacco Dependency
    Release Date:
    Review Process:
    Antimicrobial Stewardship in the Latin America Region
    Release Date:
    Review Process:
    Management of Atopic Dermatitis – International Developed Markets
    Release Date:
    Review Process:
    Improving Standard of Care for Chronic AD
    Release Date:
    Review Process:
    NCCN and Pfizer: Enhancing Academic-Community-Patient Partnerships in Metastatic Breast Cancer Care
    Release Date:
    Review Process:
    Translating the Atopic Dermatitis (AD)
    Release Date:
    Review Process:
    UK Oncology Quality Improvement Grants
    Release Date:
    Review Process: